Supernus Pharmaceuticals

SUPN

Supernus Pharmaceuticals
$36.37 $0.30 0.8%
BATS BZX Real Time Price as of April 22, 2019, 4:30 p.m. View Interactive SUPN Charts

Supernus Pharmaceuticals Inc specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system or CNS diseases.

News & Analysis: Supernus Pharmaceuticals

All

Market Moves

Earnings



3 Top Biotech Stocks to Buy in December

Find out why our healthcare contributors believe that these biotechs are great buys right now.



3 Top Biotech Stocks to Buy in November

If you don't consider adding these biotech stocks to your portfolio this month, you could wind up missing out on an opportunity.






3 Growth Stocks for Sharp Investors

On the hunt for a few stocks that hold upside potential? Here's why you should consider Starbucks, Wynn Resorts, and Supernus Pharmaceuticals.


Interactive Chart